Baxalta Incorporated (BXLT) Q2 Revenue Tops Views, Offers Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. BA
6. SPY
7. META
8. HOOD
9. INTC
10. JBLU

Go back to Baxalta Incorporated (BXLT) Q2 Revenue Tops Views, Offers Outlook

Baxalta Reports Positive Sales Momentum in Second Quarter of 2015, Raises Financial Guidance for Second Half of 2015

July 30, 2015 7:01 AM EDT

Strong second quarter sales across leading hematology and immunology portfolio ONCASPAR acquisition accelerates innovation capabilities and commercial presence in growing oncology business focused on rare and orphan diseases Critical milestone achievements and collaborations driving pipeline progress to deliver 20 new product launches by 2020

DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxalta Incorporated (NYSE: BXLT) today reported revenues for the second quarter and first half of 2015, which exceeded expectations, and provided its financial outlook for the third quarter and second half... More